Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
23 Mar 22
Current reports
8-K
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
28 Mar 24
8-K
Cost Associated with Exit or Disposal Activities
23 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
14 Dec 23
8-K
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
13 Nov 23
8-K
Other Events
30 Oct 23
8-K
Regulation FD Disclosure
10 Oct 23
8-K
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
10 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 23
8-K
Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
11 May 23
8-K
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
5 May 23
Registration and prospectus
S-8
Registration of securities for employees
28 Mar 24
S-3
Shelf registration
13 Nov 23
424B5
Prospectus supplement for primary offering
13 Nov 23
S-3
Shelf registration
5 Jun 23
424B5
Prospectus supplement for primary offering
4 May 23
424B5
Prospectus supplement for primary offering
3 May 23
S-8
Registration of securities for employees
27 Mar 23
S-3
Shelf registration
2 May 22
S-8
Registration of securities for employees
23 Mar 22
424B4
Prospectus supplement with pricing info
9 Apr 21
Other
EFFECT
Notice of effectiveness
22 Nov 23
CORRESP
Correspondence with SEC
17 Nov 23
UPLOAD
Letter from SEC
16 Nov 23
EFFECT
Notice of effectiveness
14 Jun 23
CORRESP
Correspondence with SEC
9 Jun 23
UPLOAD
Letter from SEC
8 Jun 23
EFFECT
Notice of effectiveness
10 May 22
CORRESP
Correspondence with SEC
5 May 22
UPLOAD
Letter from SEC
4 May 22
EFFECT
Notice of effectiveness
9 Apr 21
Ownership
SC 13G
Octagon Capital Advisors LP
5 Feb 24
SC 13G
BML Investment Partners, L.P.
17 Jan 24
SC 13D
TANG CAPITAL PARTNERS LP
26 Dec 23
SC 13D/A
Novo Holdings A/S
15 Dec 23
4
Ashley Hall
29 Aug 23
144
Notice of proposed sale of securities
28 Aug 23
4
MICHAEL G GREY
27 Jul 23
4
Change in insider ownership
23 Jun 23
144
Notice of proposed sale of securities
23 Jun 23
4
Edward T Mathers
8 Jun 23